Condition

Nausea and Vomiting Caused by Trastuzumab Deruxtecan

ClinicalTrials.gov condition label

Clinical trials2

Recruiting2

Common interventions3

Lead sponsors shown1

Clinical trials

2 shown

Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Trastuzumab DeruxtecanNCT07716189 · 2025-12-12

RECRUITING

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab DeruxtecanNCT07537673 · 2025-11-25

RECRUITING

Common interventions

Auricular point stimulation plus dexamethasoneDRUG1Auricular point stimulation plus dexamethasoneOTHER1Standard pharmacologic antiemetic regimenDRUG1

Leading sponsors

Second Affiliated Hospital, Zhejiang University, School of Medicine2

Trial status mix

RECRUITING2

Phase mix

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.